Impact Biomedical (IBO) Cash & Equivalents (2022 - 2026)
Impact Biomedical's Cash & Equivalents was $10,000 in Q2 2026, down 98.4% from $624,000 a year earlier and down 50.0% from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Impact Biomedical came in at $3,000, down 99.8% from FY2024.
- Cash & Equivalents shows a three-year compound annual growth rate of 14.5% (FY2022 to FY2025).
- In earlier years, Cash & Equivalents was $2 million in FY2024, $1,000 in FY2023 (-50.0%) and $2,000 in FY2022.
- Quarterly Cash & Equivalents has moved between $1,000 (Q4 2023) and $2.67 million (Q3 2024) over five years.
- Compared with a year earlier, Cash & Equivalents has declined for four straight quarters, with an average decline of 99.1% over the last four quarters.
- Per Business Quant data, IBO's Cash & Equivalents in the three quarters before Q2 2026 was $20,000 (Q1 2026), $3,000 (Q4 2025) and $12,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Impact Biomedical | 573.61 Mn | 576.81 Mn | 2,000.00 | 10,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 624,000.00 |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 201,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Dec 31, 2022 | 2,000.00 |
API Access
Impact Biomedical Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();